Author

Jessica Oldham

Observed name: J. Oldham

Observed institutions: American Society of Clinical Oncology, Mayo Clinic, Memorial Sloan Kettering Cancer Center, Harvard University, Johns Hopkins University, Abington Memorial Hospital, Massachusetts General Hospital, Dana-Farber Cancer Institute, Woman's Cancer Foundation, Arizona Oncology, Sidney Kimmel Comprehensive Cancer Center

OpenAlex ID: A5026654792

Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline

2016 · Alexi A. Wright, Kari Bohlke, et al. · Journal of Clinical Oncology · 410

Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline

2016 · Alexi A. Wright, Kari Bohlke, et al. · Gynecologic Oncology · 362

Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline

2016 · Alexi A. Wright, Kari Bohlke, et al. · Obstetrical & Gynecological Survey · 34

What are We Worth: An Sgo Analysis of the Compensation Structure Complexity Measuring Value Work in Academic Gynecologic Oncology Practices

2025 · Jessica Oldham, Margaret I. Liang, et al. · SSRN Electronic Journal

Updates to Post-Treatment Surveillance after Curative Intent Treatment for Patients with Gynecologic Cancers: A Society of Gynecologic Oncology Clinical Practice Statement

2025 · Jessica Oldham, Ritu Salani, et al. · SSRN Electronic Journal

The Society of Gynecologic Oncology wellness curriculum pilot: A groundbreaking initiative for fellowship training

2019 · T.B. Turner, D.M. Kushner, et al. · Gynecologic Oncology

Works count: 6

Citation count: 806

H-index: 3

I10-index: 3